Holen Sie sich die Stockscreener-App
28.85
3.81%
1.06
Schlusskurs vom Vortag:
$27.79
Offen:
$26.97
24-Stunden-Volumen:
283.14K
Relative Volume:
0.75
Marktkapitalisierung:
$477.12M
Einnahmen:
$3.25M
Nettoeinkommen (Verlust:
$-116.80M
KGV:
-9.459
EPS:
-3.05
Netto-Cashflow:
$-98.17M
1W Leistung:
-0.03%
1M Leistung:
+15.40%
6M Leistung:
+380.71%
1J Leistung:
+181.74%
1-Tages-Spanne:
$26.78
$29.27
1-Wochen-Bereich:
$26.78
$30.12
52-Wochen-Spanne:
$5.6652
$42.39
Rapt Therapeutics Inc Stock (RAPT) Company Profile
Firmenname
Rapt Therapeutics Inc
Sektor
Branche
Telefon
(650) 489-9000
Adresse
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Vergleichen Sie RAPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RAPT
Rapt Therapeutics Inc
|
28.85 | 770.09M | 3.25M | -116.80M | -98.17M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-27 | Eingeleitet | Guggenheim | Buy |
| 2025-10-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-10-13 | Eingeleitet | Barclays | Overweight |
| 2025-09-26 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-07-30 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2025-05-22 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-12-26 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-11-13 | Herabstufung | Stifel | Buy → Hold |
| 2024-11-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-11-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-14 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-05-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-22 | Herabstufung | UBS | Buy → Neutral |
| 2024-02-21 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-02-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-21 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-02-20 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-02-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-09-14 | Eingeleitet | Berenberg | Buy |
| 2023-08-09 | Eingeleitet | Stifel | Buy |
| 2023-06-15 | Eingeleitet | Barclays | Overweight |
| 2023-01-04 | Eingeleitet | Guggenheim | Buy |
| 2022-12-01 | Eingeleitet | Goldman | Buy |
| 2022-09-21 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-12-09 | Eingeleitet | JP Morgan | Overweight |
| 2021-08-12 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-21 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-04-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-11-25 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-11-25 | Eingeleitet | UBS | Buy |
| 2019-11-25 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Rapt Therapeutics Inc Aktie (RAPT) Neueste Nachrichten
What to expect from RAPT Therapeutics Inc. in the next 30 daysJuly 2025 Retail & Safe Swing Trade Setups - newser.com
Why RAPT Therapeutics Inc. stock appeals to dividend seekersPortfolio Return Report & Free Accurate Trade Setup Notifications - newser.com
How RAPT Therapeutics Inc. (0RA0) stock stacks up against competitorsProfit Target & Fast Exit/Entry Strategy Plans - newser.com
Is RAPT Therapeutics Inc. stock reversal real or fakeJuly 2025 Price Swings & Consistent Growth Equity Picks - newser.com
Leading vs lagging indicators on RAPT Therapeutics Inc. performanceEntry Point & Real-Time Market Trend Scan - newser.com
RAPT Therapeutics Inc. recovery potential after sell offJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - newser.com
How RAPT Therapeutics Inc. stock benefits from tech adoptionWeekly Profit Report & Growth Focused Investment Plans - newser.com
Does RAPT Therapeutics Inc. (0RA) stock trade below intrinsic value2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com
Can RAPT Therapeutics Inc. recover in the next quarterMarket Volume Summary & Safe Capital Growth Trade Ideas - newser.com
Why RAPT Therapeutics Inc. (0RA) stock is trending on social mediaQuarterly Trade Report & AI Forecasted Entry and Exit Points - newser.com
Why retail investors favor RAPT Therapeutics Inc. stock2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Can RAPT Therapeutics Inc. (0RA) stock attract ESG investments2025 Institutional Moves & Weekly Breakout Watchlists - newser.com
Can RAPT Therapeutics Inc. (0RA) stock resist broad market declinesEarnings Recap Report & AI Based Buy and Sell Signals - newser.com
What to do if you’re stuck in RAPT Therapeutics Inc.July 2025 Sentiment & AI Driven Stock Price Forecasts - newser.com
Technical signs of recovery in RAPT Therapeutics Inc.Fed Meeting & Daily Chart Pattern Signal Reports - newser.com
How institutional buying supports RAPT Therapeutics Inc. stock2025 Winners & Losers & Technical Pattern Based Buy Signals - newser.com
What macro factors could drive RAPT Therapeutics Inc. (0RA0) stock higherJuly 2025 Intraday Action & Short-Term Trading Alerts - newser.com
Can RAPT Therapeutics Inc. stock outperform in 2025 bull marketMarket Movers & Accurate Buy Signal Notifications - newser.com
RAPT Therapeutics: Strong Promise In Immunology, Looks Like An Opportunity At These Prices - Seeking Alpha
Can RAPT Therapeutics Inc. (0RA) stock survive global slowdownJuly 2025 WrapUp & Risk Adjusted Swing Trade Ideas - newser.com
Can RAPT Therapeutics Inc. (0RA) stock ride next bull market cycle2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Will RAPT Therapeutics Inc. (0RA) stock beat revenue estimatesJuly 2025 Fed Impact & Verified Entry Point Signals - Fundação Cultural do Pará
Will RAPT Therapeutics Inc. (0RA0) stock outperform value peers2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
Can RAPT Therapeutics Inc. (0RA0) stock sustain margin levelsChart Signals & High Win Rate Trade Tips - newser.com
Is RAPT Therapeutics Inc. (0RA0) stock a buy before earnings resultsJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Finanzdaten der Rapt Therapeutics Inc-Aktie (RAPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):